Early pregnancy factor: An extracellular chaperonin 10 homologue

Immunology and Cell Biology

Volumn 76, Issue 6, 1998, Pages 483-496

  Morton, Halle ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chaperonin 10; Early pregnancy factor; Experimental autoimmune encephalomyelitis; Growth factor; Heat shock proteins; Immunoregulation; Lymphokines; Pregnancy; Pregnancy proteins; Rosette inhibition test

Indexed keywords

CHAPERONIN; EARLY PREGNANCY FACTOR; GROWTH FACTOR; HEAT SHOCK PROTEIN; LYMPHOKINE; PLACENTA PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CELL PROLIFERATION; EMBRYO GROWTH; HUMAN; IMMUNOREGULATION; LABORATORY TEST; MULTIPLE SCLEROSIS; NONHUMAN; PREGNANCY TEST; REVIEW; ROSETTE FORMATION; SURVIVAL; TUMOR CELL;

ANIMALS; CELLS, CULTURED; CHAPERONIN 10; EMBRYO; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GROWTH SUBSTANCES; HEAT-SHOCK PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC TESTS; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; RATS;

ANIMALIA;

EID: 0032436515     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00782.x     Document Type: Review

References (133)

1. Medawar PB. Some immunological and endrocrinologicul problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 1953; 7: 320-38.
2. Billington WD. Transfer of antigens and antibodies between mother and foetus. In: Coulam CB. Faulk WP, McIntyre JA (eds) Immunological Obstetrics. New York: WW Norton & Company, 1992; 290-304.
3. Medawar PB. Immunity to homologous grafted skin. III. Fate of skin homografts transplanted to brain, to subcutaneous tissue and to anterior chamber of the eye. Br. J. Exp. Pathol. 1948; 29: 58-69.
4. Billingham RE, Silvers WK. Studies on cheek pouch skin grafts in Syrian hamster. In: Wolstenholme GEW, Cameron MP (eds) Ciba Foundation Symposium on Transplantation. Boston: Little, Brown, 1962; 90-108.
5. Starzl TE, Porter KA, Iwasaki Y, Marchioro TL, Kashiwagi N. The use of heterologous anti-lymphocyte globulin in human renal homotransplantation. In: Wolstenholme GEW, O'Connor M (eds) Anti-lymphocyte serum. Ciba Foundation Study Group no. 29. London: Churchill, 1967; 4-40.
6. Bach JF, Dormont J, Dardenne M, Balner H. In vitro rosette inhibition by anti-human ALS: Correlation with skin graft prolongation in primates. Transplantation 1969; 8: 265-80.
7. Morton H, Hegh V, Clunie GJA. Immunosuppression detected in pregnant mice by the rosette inhibition test. Nature 1974; 249: 459-60.
8. Morton H, Hegh V, Clunie GJA. Studies of the rosette inhibition test in pregnant mice: Evidence of immunosuppression? Proc. R. Soc. Lond. B. 1976; 193: 413-19.
9. Short RV. Implantation and maternal recognition of pregnancy. In: Wolstenholme GEW, O'Connor M (eds) Ciba Foundation Symposium: Foetal Autonomy. London: Churchill, 1969; 2-26.
10. Athanasas S, Quinn KA, Wong T-Y, Rolfe BE, Cavanagh AC, Morton H. Passive immunization of pregnant mice against early pregnancy factor causes loss of embryonic viability. J. Reprod. Fertil. 1989; 87: 495-502.
11. Athanasas-Platsis S, Morton H, Dunglison GF, Kaye PL. Antibodies to early pregnancy factor retard embryonic development in mice in vivo. J. Reprod. Fertil. 1991; 92: 443-51.
12. Noonan FP, Halliday WJ, Morton H, Clunie GJA. Early pregnancy factor is immunosuppressive. Nature 1979; 278: 649-51.
13. Athanasas-Platsis S. Early pregnancy factor: A study of its immunomodulatory and growth regulatory properties during pregnancy. PhD Thesis, University of Queensland. Queensland, Australia. 1993.
14. Quinn KA, Athanasas-Platsis S, Wong T-Y, Rolfe BE, Cavanagh AC, Morton H. Monoclonal antibodies to early pregnancy factor perturb tumour cell growth. Clin. Exp. Immunol. 1990; 80: 100-8.
15. Quinn KA, Morton H. Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours. Cancer Immunol. Immunother. 1992; 34: 265-71.
16. Quinn KA, Cavanagh AC, Hillyard NC, McKay DA, Morton H. Early pregnancy factor in liver regeneration after partial hepatectomy in rats: Relationship to chaperonin 10. Hepatology 1994; 20: 1294-302.
17. Cavanagh AC, Rolfe BE, Athanasas-Platsis S, Quinn KA, Morton H. Relationship between early pregnancy factor, mouse embryo-conditioned medium and platelet-activating factor. J. Reprod. Fertil. 1991; 93: 355-65.
18. Cavanagh AC, Morton H. Chaperonin 10. International Patent Application PCT/AU94/00742. IP Australia, Brisbane, Qld, Australia. 1995.
19. Cavanagh AC, Morton H. Early pregnancy factor: Purification to homogeneity from human platelets and identification as chaperonin 10. Eur. J. Biochem. 1994; 222: 551-60.
20. Hartman DJ, Hoogenraad NJ, Condron R, Hoj PB. Identification of a mammalian 10-kDa heat shock protein, a mitochondrial chaperonin 10 homologue essential for assisted folding of trimeric ornithine transcarbamoylase in vitro. Proc. Natl Acad. Sci. USA 1992; 89: 3394-8.
21. Love SG, Englebretsen DR, Garnham B et al. Observation of protein heptamer formation for chemically ligated early pregnancy factor. In: Ens W, Standing KG. Cherushevich IV (eds) NATO ASI Series. Series C: Mathematical and Physical Sciences, vol. 510: New Methods for the Study of Biomolecular Complexes, Netherlands: Kluwer Academic Publishers, 1998; 171-9.
22. Zeilstra-Ryalls J, Fayet O, Georgopoulos C. The universally conserved groE (hsp60) chaperonins. Annu. Rev. Microbiol. 1991; 45: 301-25.
23. Morton H, Cavanagh AC. Antagonists to Chaperonin 10. International Patent Application PCT/AU94/00742. IP Australia, Brisbane, Qld, Australia. 1995.
24. Somodevilla Torres MJ. Role of chaperonin 10 in the growth of tumour cells. MMSc (Qual). University of Queensland, Brisbane, Queensland, Australia. 1994.
25. Summers KM, Murphy RM, Webb GC et al. The human early pregnancy factor/chaperonin 10 gene family. Biochem. Mol. Med. 1996; 58: 52-8.
26. Ryan MT, Hoogenraad NJ, Hoj PB. Isolation of a cDNA clone specifying rat chaperonin 10, a stress inducible mitochondrial matrix protein synthesized without a cleavable presequence. FEBS Lett. 1994; 337: 152-6.
27. Muesch A, Hartmann E, Rohde K, Rubartelli A, Sitia R. Rapoport TA. A novel pathway for secretory proteins? Trends Biochem. Sci. 1990; 15: 86-8.
28. Ellis RJ, van der Vies SM. Molecular chaperones. Annu. Rev. Biochem. 1991; 60: 321-47.
29. Kaufmann SHE. Heat shock proteins and the immune response. Immunol. Today 1990; 11: 129-36.
30. Kaufmann SHE. Heat Shock Proteins and Immune Response. Current Topics in Microbiology and Immunology, vol. 167. Berlin: Springer-Verlag, 1991.
31. Young RA. Stress proteins and immunology. In: Paul WE, Fathman CG, Metzger H (eds) Annu. Rev. Immunol. 1990; 8: 401-20.
32. Gao YL, Brosnan CF, Raine CS. Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. J. Immunol. 1995; 154: 3548-56.
33. Mizzen L. Immune responses to stress proteins: Applications to infectious disease and cancer. Biotherapy 1998; 10: 173-89.
34. Multhoff G, Botzler C, Issels R. The role of heat shock proteins in the stimulation of an immune response. Biol. Chem. 1998; 379: 295-300.
35. Haas IG, Wabi M. Immunoglobulin heavy chain binding protein. Nature 1983; 306: 387-9.
36. Townsend A, Ohlen C, Bastin J, Ljunggren H-G, Foster L, Karra K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989; 340: 443-8.
37. Parham P. A profitable lesson in heresy. Nature 1989; 340: 426-8.
38. Kaufmann SHE, Kabelitz D. Gamma/delta T lymphocytes and heat shock proteins. In: Kaufmann SHE (ed.) Heat Shock Proteins and Immune Response. Current Topics in Microbiology and Immunology, vol. 167. Berlin: Springer-Verlag, 1991; 191-207.
39. St John T, Gallatin WM, Siegelman M, Smith HT, Fried VA, Weissman IL. Expression cloning of a lymphocyte homing receptor cDNA: Ubiquitin is the reactive species. Science 1986; 231: 845-50.
40. Kaufmann SHE. Heat shock protein and autoimmunity: A critical appraisal. Int Arch. Allergy Immunol. 1994; 103: 317-22.
41. Lindquist S, Craig EA. The heat shock proteins. Annu. Rev. Genet. 1988; 22: 631-77.
42. Hightower LE, Guidon Jr PT. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J. Cell. Physiol. 1989; 138: 257-66.
43. Anderton SM, van der Zee R, Prakken B, Noordzij A, van Eden W. Activation of T cells recognizing self 60-kD heat shock proteins can protect against experimental arthritis. J. Exp. Med. 1995; 181: 943-52.
44. van Eden W, van der Zee R, Paul AGA et al. Do heat shock proteins control the balance of T-cell regulation in inflammatory disease? Immunol. Today 1998; 19: 303-7.
45. Birnbaum G, Kotilinek L. Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann. NY Acad. Sci. 1997; 835: 157-67.
46. Ragno S, Winrow VR, Mascagni P et al. A synthetic 10-kD heat shock proteins (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin. Exp. Immunol. 1996; 103: 384-90.
47. Ben-Nun A, Mendel I, Sappler G, Kerlero de Rosbo N. A 12-kDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis. Protection in the absence of shared T cell epitopes with encephalitogenic proteins. J. Immunol. 1995; 154: 2939-48.
48. Ferrero RL, Thiberge J-M, Kansau I, Wusher N, Huerre M, Labigne A. The groES of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc. Natl Acad. Sci. USA 1995; 92: 6499-503.
49. Wilson S, McCarthy R, Clarke FM. In search of early pregnancy factor: Isolation of active polypeptides from pregnant ewes sera. J. Reprod. Immunol. 1983; 5: 275-86.
50. Cavanagh AC. Production in vivo of mouse early pregnancy factor and purification to homogeneity. J. Reprod. Fertil. 1984: 71: 581-92.
51. Bose R, Cheng H, Sabbadini E, McCoshen J, Madadevan MM, Fleetham J. Purified human early pregnancy factor from preimplantation embryos possess immunosuppressive properties. Am. J. Obstet. Gynecol. 1989; 160: 954-60.
52. Mehta AR, Eessalu TE, Aggarwal BB. Purification and characterization of early pregnancy factor from human pregnancy serum. J. Biol. Chem. 1989; 264: 2266-71.
53. Ito K, Ikemizu Y, Takahashi J, Yasuda Y, Kawahata K, Goto T. Early pregnancy factor; EPF-like substance(s) purified from pregnant bovine ovary and in vitro fertilized ovum culture medium. J. Reprod. Dev. 1995; 41: 85-92.
54. Cavanagh AC, Morton H, Athanasas-Platsis S, Quinn KA, Rolfe BE. Identification of a putative inhibitor of early pregnancy factor in mice. J. Reprod. Fertil. 1991; 91: 239-48.
55. Morton H, Rolfe BE, McNeill L, Clarke P, Clarke FM, Clunie GJA. Early pregnancy factor: Tissues involved in its production in the mouse. J. Reprod. Immunol. 1980; 2: 73-82.
56. Morton H. Early pregnancy factor (EPF): A link between fertilization and immunomodulation. Aust. J. Biol. Sci. 1984; 37: 393-407.
57. Rolfe BE, Cavanagh AC, Quinn KA, Morton H. Identification of two suppressor factors induced by early pregnancy factor. Clin. Exp. Immunol. 1988; 73: 219-25.
58. Rolfe B, Quinn K, Athanasas S, Cavanagh A, Morton H. Genetically-restricted effector molecules released by human lymphocytes in response to early pregnancy factor. Immunol. Cell Biol. 1989; 67: 205-8.
59. Clarke FM, Morton H, Clunie GJA. Detection and separation of two serum factors responsible for depression of lymphocyte activity in pregnancy. Clin. Exp. Immunol. 1978; 32: 318-23.
60. Clarke FM, Morton H, Rolfe BE, Clunie GJA. Partial characterization of early pregnancy factor in the sheep. J. Reprod. Immunol. 1980; 2: 151-62.
61. Morton H, Morton DJ, Ellendorff F. The appearance and characteristics of early pregnancy factor in the pig. J. Reprod. Fertil. 1983; 68: 437-46.
62. Rolfe BE, Morton H, Clarke FM. Early pregnancy factor is an immunosuppressive contaminant of commercial preparations of human chorionic gonadotrophin. Clin. Exp. Immunol. 1983; 51: 45-52.
63. Hall K, Lundin G, Povoa G. Serum levels of the low molecular weight form of insulin-like growth factor binding proteins in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinol. Copenh. 1988; 118: 321-6.
64. Clarke FM. Identification of molecules and mechanisms involved in the 'early pregnancy factor' system. Reprod. Fertil. Dev. 1992; 4: 423-33.
65. Lash GE. Early pregnancy factor: Induction of activity in mice. PhD Thesis. University of Otago, Dunedin, New Zealand. 1996.
66. Cavanagh AC. An update on the identity of early pregnancy factor and its role in early pregnancy. J. Assist. Reprod. Genet. 1997; 14: 492-5.
67. Morton H, Rolfe B, Clunie GJA. An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet 1977; 1: 394-7.
68. Morton H, Tinneberg H-R, Rolfe B, Wolf M, Mettler L. Rosette inhibition test: A multicentre investigation of early pregnancy factor in humans. J. Reprod. Immunol. 1982; 4: 251-61.
69. Rolfe BE. Detection of fetal wastage. Fertil. Steril. 1982; 37: 655-60.
70. Smart YC, Roberts TK, Fraser IS, Cripps AW, Clancy RL. Validation of the rosette inhibition test for the detection of early pregnancy in women. Fertil. Steril. 1982; 37: 779-85.
71. Tinneberg HR, Staves RP, Semm K. Improvement of the rosette inhibition assay for the detection of early pregnancy factor in humans using the monoclonal antibody, anti-human-Lyt-3. Am. J. Reprod. Immunol. 1984; 5: 151-6.
72. Chen C, Jones WR, Bastin F, Forde C. Monitoring post-transfer embryos following in vitro fertilization. Ann. NY Acad. Sci. 1985; 442: 420-8.
73. Igarashi S. Studies of early pregnancy factor by rosette inhibition test using monoclonal antibodies. Acta Obstet. Gynaecol. Jpn 1984; 36: 519-24.
74. Qin Z, Zheng Z-Q. Detection of early pregnancy factor in human sera. Am. J. Reprod. Immunol. Microbiol. 1987; 13: 15-18.
75. Morton H, Nancarrow CD, Scaramuzzi RJ, Evison BM, Clunic GJA. Detection of early pregnancy in sheep by the rosette inhibition test. J. Reprod. Fertil. 1979; 56: 75-80.
76. Koch E, Morton H, Ellendorff F. Early pregnancy factor: biology and practical application. Br. Vet. J. 1983; 139: 52-8.
77. Yoshioka K, Iwamursa S, Kamomae H. Application of antibovine CD2 monoclonal antibody to the rosette inhibition test for detection of early pregnancy factor in cattle. J. Vet. Med. Sci. 1995; 57: 721-5.
78. Yamazaki S, Kawahata K, Goto T, Takahashi J, Yasuda Y. EPF as a marker for early embryonic losses in repeat breeders. J. Reprod. Dev. 1995; 41: 129-32.
79. Lash GE, Legge M, Fisher M. Synthesis of early pregnancy factor using red deer (Cervus elaphus) as a delayed implantation model. J. Assist. Reprod. Genet. 1997; 14: 39-43.
80. Cavanagh AC, Morton H. EPF: Embryo detector and molecular chaperone. Today's Life Sci. 1996; 8: 24-7.
81. Morton H, Rolfe BE, Cavanagh AC. Ovum factor and early pregnancy factor. Curr. Top. Der. Biol. 1987; 23: 73-92.
82. Lash GE, Legge M. Early pregnancy factor: An unresolved molecule. J. Assist. Reprod. Genet. 1997; 14: 495-6.
83. Nancarrow CD, Evison BM, Scaramuzzi RJ, Turnbull KE. Detection of induced death of embryos in sheep by the rosette inhibition test. J. Reprod. Fertil. 1979; 57: 385-9.
84. Mettler L, Hanf V, Tineberg H-R. Comparison of serum activity of early pregnancy factor (EPF) and relevant hormones before and after therapeutic abortion. In: Ellendorff F, Koch E (eds) Early Pregnancy Factors. New York: Perinatology Press, 1985; 227-31.
85. 1). Am. J. Reprod. Immunol. 1995; 33: 259-66.
86. Robinson GA, Butcher RW, Sutherland EW. Cyclic AMP. London: Academic Press, 1971.
87. Tada T. Help, suppression and specific factors. In: Paul WE (ed.) Fundamental Immunology. New York: Raven Press, 1984; 481-517.
88. Igarashi S. Significance of early pregnancy factor (EPF) on reproductive immunology. Acta Obstet. Gynecol. Jpn 1987; 39: 189-94.
89. 1) disrupts implantation in mice. Am. J. Reprod. Immunol. 1995; 33: 259-66.
90. Hill JA, Haimovici F, Anderson DJ. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J. Immunol. 1987; 139: 2250-4.
91. Rolfe BE, Morton H, Cavanagh AC, Gardiner RA. Detection of an early pregnancy factor-like substance in sera of patients with testicular germ cell tumours. Am. J. Reprod. Immunol. 1983; 3: 97-100.
92. Mehta AR, Shahani SK. Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumours. Am. J. Reprod Immunol. Microbiol. 1987; 14: 67-9.
93. Haubeck HD, Kolsch E. Isolation and characterisation of in vitro and in vivo functions of a tumour-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma. J. Immunol. 1985; 135: 4297-302.
94. Quinn KA. Early pregnancy factor: A novel factor involved in cellular proliferation. PhD Thesis. University of Queensland, Brisbane, Queensland, Australia. 1991.
95. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc. Natl Acad. Sci. USA 1988; 85: 1539-43.
96. Fausto N, Mead J. Biology of disease: Regulation of liver growth: Protooncogenes and transforming growth factors. Lab. Invest. 1989; 60: 4-13.
97. Fujio F, Hatayama T, Kinoshita H, Yukioka M. Induction of mRNAs for heat shock proteins in livers of rats after ischemia and partial hepatectomy. Mol. Cell. Biochem. 1987; 77: 173-7.
98. Carr BI, Huang TH, Buzin CH, Itakura K. Induction of heat shock gene expression without heat shock by hepatocarcino gene and during hepatic regeneration in rat livers. Cancer Res. 1986; 46: 5106-11.
99. Gorczynski RM, Chung S, Hoang Y, Sullivan B, Chen Z. Altered patterns of migration of cytokine-producing T lymphocytes in skin-grafted naïve or immune mice following in vivo administration of anti-VCAM-1 or -ICAM-1. Immunology 1996; 87: 573-80.
100. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol. Today 1993; 14: 353-6.
101. Chaouat G, Diallo JT, Volumenie JL et al. Immune suppression and Th1/Th2 balance in pregnancy revisited: A (very) personal tribute to Tom Wegmann. Am. J. Reprod. Immunol. 1997; 37: 427-34.
102. Keith AB. Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats. J. Neurol. Sci. 1978; 38: 317-26.
103. Mertin LA, Rumjanek VM. Pregnancy and the susceptibility of Lewis rats to experimental allergic encephalomyelitis. J. Neurol. Sci. 1985; 68: 15-24.
104. Frith JA, McLeod JG. Pregnancy and multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1988; 51: 495-8.
105. Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: A cohort study. Acta Neurol. Scand. 1991; 84: 403-6.
106. van Walderveen MA, Tas MW, Barkhof F. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 1994; 44: 327-9.
107. Duquette P, Girard M. Hormonal factors in susceptibility to multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 1993; 6: 195-201.
108. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118: 253-61.
109. Hutchinson M. Pregnancy in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1993; 56: 1043-5.
110. McCombe PA, Fordyce BW, de Jersey J, Yoon G, Pender MP. Expression of CD45RC and Ia antigen in the spinal cord in acute experimental allergic encephalomyelitis: An immunocytochemical and flow cytometric study. J. Neurol. Sci. 1992; 113: 177-86.
111. Jones MC, MacLeod AM, Dillon DM, Catto GR. The maternal immune response. In: Coulam CB, Faulk WP, McIntyre JA (eds) Immunological Obstetrics. New York: WW Norton & Company, 1992; 227-44.
112. Stimson WH, Hunter IC. An investigation into the immunosuppressive properties of oestrogen. J. Endrocrinol. 1976; 69: 42-3.
113. Szekeres J, Fabian G, Pasca AS, Pejtsik B. Dialyzable serum factors after cellular immunity in pregnancy. Experientia 1981; 37: 515-16.
114. Hagan C, Froland A. Depressed lymphocyte response to PHA in women taking oral contraceptives. Lancet 1972; 1: 1185.
115. Barnes EW, Maccuish AC, Landon NB, Jordan J, Irvine WJ. Phytohaemagglutinin-induced lymphocyte transformation and circulating autoantibodies in women taking oral contraceptives. Lancet 1974; 1: 898-900.
116. Stimson WH. Identification of pregnancy-associated α-macroglobulin on the surface of peripheral blood leukocyte population. Clin. Exp. Immunol. 1977; 28: 445-52.
117. Lippman ME. Glucocorticoid receptors and the effects in human lymphoid and leukaemic cells. Monogr. Endrocrinol. 1979; 12: 377-97.
118. Lee CK, Chosal K, Beaman KD. Cloning of a cDNA for a T-cell produced molecule with a putative immune regulatory role. Mol. Immunol. 1990; 27: 1137-44.
119. Nichols TC, Kang JA, Angkachatchai V, Beer A, Beaman KD. Expression of a membrane form of the pregnancy-associated protein TJ6 on lymphocytes. Cell. Immunol. 1994; 155: 219-29.
120. Mandal M, Beaman KD. Purification and characterization of a pregnancy-associated protein: TJ6s. Am. J. Reprod. Immunol. 1995; 33: 60-7.
121. Carpenter G, Whal MI. The epidermal growth factor family. In: Sporn MB, Roberts AB (eds) Peptide Growth Factors and their Receptors I. New York: Springer-Verlag, 1990; 69-171.
122. Anklesaria P, Teixido J, Laiho M, Pierce JH, Greenberger JS, Massague J. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor α to epidermal growth factor receptors promotes cell proliferation. Proc. Natl Acad. Sci. USA 1990; 87: 3289-93.
123. Rettenmeir CW, Roussel MF, Ashmun RA, Ralph P, Pierce K, Sherr CJ. Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and down modulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol. Cell. Biol. 1987; 7: 2378-87.
124. Godkin JD, Bazer FW, Moffatt J, Sessions F, Roberts RM. Purification and properties of a major, low molecular weight protein released by the trophoblast of sheep blastocyst at day 13-21. J. Reprod. Fertil. 1982; 65: 141-50.
125. Pontzer CH, Ott TL, Bazer FW, Johnson HM. Structure/ function studies with interferon tau: Evidence for multiple active sites. J. Interferon Res. 1994; 14: 133-41.
126. Guillomot M, Reinaud P, La Bonnardiere C, Charpigny G. Characterization of conceptus-produced goat interferon tau and analysis of its temporal and cellular distribution during early pregnancy. J. Reprod. Fertil. 1998; 112: 149-56.
127. Whaley AE, Meka CS, Hunt JS, Imakawa K. Identification and cellular localization of unique interferon mRNA from human placenta. J. Biol. Chem. 1994; 269: 10864-8.
128. Soos JM, Subramaniam PS, Hobeika AC, Schiffenbauer J, Johnson HM. The IFN pregnancy recognition hormone IFN-τ blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J. Immunol. 1995; 155: 2747-53.
129. Soos JM, Mujtaba MG, Subramaniam PS, Streit WJ, Johnson HM. Oral feeding of interferon τ can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis. J. Neuroimmunol. 1997; 75: 43-50.
130. Mujtaba MG, Soos JM, Johnson HM. CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitis. J. Neuroimmunol. 1997; 75: 35-42.
131. Morton H, Cavanagh AC, Athanasas-Plalsis S, Quinn KA, Rolfe BE. Early pregnancy factor has immunosuppressive and growth factor properties. Repros. Fertil. Dev. 1992; 4: 411-22.
132. Cavanagh AC, Morton H, Rolfe BE, Gidley-Baird AA. Ovum factor: A first signal of pregnancy? Am. J. Reprod. Immunol. 1982; 2: 97-101.
133. Morton H, Rolfe BE, Cavanagh AC. Early pregnancy factor. Semin. Reprod. Endrocrinol. 1992; 10: 72-82.